Arsenic trioxide for the treatment of medium and advanced primary liver cancer.
- Author:
Jun QIAN
1
;
Shukui QIN
;
Zeming HE
;
Lin WANG
;
Yingxia CHEN
;
Zhijian SHAO
;
Xiufeng LIU
Author Information
1. PLA Cancer Center of the 81st hospital, Nanjing 210002, China.
- Publication Type:Clinical Trial
- MeSH:
Adult;
Aged;
Antineoplastic Agents;
adverse effects;
therapeutic use;
Arsenicals;
adverse effects;
therapeutic use;
Chemical and Drug Induced Liver Injury;
Female;
Humans;
Liver Neoplasms;
drug therapy;
Male;
Middle Aged;
Oxides;
adverse effects;
therapeutic use;
Remission Induction;
Treatment Outcome;
Vomiting;
chemically induced
- From:
Chinese Journal of Hepatology
2002;10(1):63-63
- CountryChina
- Language:Chinese
